Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma: a Multicenter Observational Study

NCT06113081 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT06113081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06113081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma: a Multicenter Observational Study
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Observational
Overall status
Completed
Start date
June 6, 2024
Completion date
November 11, 2025
Enrollment
100 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous t cell lymphoma, cutaneous t-cell lymphoma/mycosis fungoides, cutaneous t-cell lymphoma/sezary syndrome